Anthony Daniels Archives
Hope On Wheels grant to enhance retinoblastoma research
Aug. 20, 2020—Anthony Daniels, MD, MSc, has been awarded a $300,000 Hyundai Hope On Wheels Scholar Grant to study the design of more precise drugs to treat retinoblastoma, the most common ocular cancer in children.
The Alliance for Eye and Vision Research honors two from VEI
Sep. 8, 2016—Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR).
Two receive Research to Prevent Blindness grants
Jul. 21, 2016—Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.
Gifts highlight strong, lasting bonds between patients and healers
Mar. 24, 2016—Sometimes saying thank you just isn’t enough.
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.
Novel therapy eases stress of retinoblastoma treatment
Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
